...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Functional crosstalk of prejunctional receptors on the modulation of noradrenaline release in mesenteric vessels: A differential study of artery and vein.
【24h】

Functional crosstalk of prejunctional receptors on the modulation of noradrenaline release in mesenteric vessels: A differential study of artery and vein.

机译:结膜前受体在肠系膜血管中去甲肾上腺素释放调节中的功能性串扰:动脉和静脉的差异研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The role of angiotensin II receptors, bradykinin receptors and beta-adrenoceptors in the modulation of noradrenaline release and the influence of alpha(2)-autoinhibition in these effects was investigated in the mesenteric artery and vein. Rings of mesenteric vessels of male Wistar rats were labelled with [(3)H]-noradrenaline and the effects of modulators on tritium overflow evoked by 100 pulses at 2Hz (marked alpha(2)-autoinhibition) and by 20 pulses at 50Hz or 100 pulses at 2Hz plus yohimbine (1muM; reduced alpha(2)-autoinhibition) were evaluated. Angiotensin II and bradykinin enhanced noradrenaline release evoked by 100 pulses at 2Hz, in a concentration-dependent manner, in both vessels. These effects were attenuated under conditions of reduced alpha(2)-autoinhibition. The attenuation was partially reversed by activation of adenosine A(1) receptors in both vessels and by activation of P2Y receptors in the vein. Isoprenaline and the selective beta(2)-adrenoceptor agonist formoterol enhanced tritium overflow independently of alpha(2)-autoinhibition in the vein. In the artery, the enhancement by formoterol was only observed under reduced alpha(2)-autoinhibition. Pharmacological characterization of the beta-adrenoceptors indicated that in the artery the effect of isoprenaline was mediated by the beta(1)-subtype under marked alpha(2)-autoinhibition and by the beta(2)-subtype under reduced alpha(2)-autoinhibition whereas in the vein the effect was independent of alpha(2)-autoinhibition. The results indicate that alpha(2)-autoinhibition is a key determinant of the magnitude of facilitation caused by angiotensin II and bradykinin in both types of mesenteric vessels and regulates the effects mediated by beta(1)-and beta(2)-adrenoceptors which co-exist in the artery.
机译:在肠系膜动脉和静脉中研究了血管紧张素II受体,缓激肽受体和β-肾上腺素受体在去甲肾上腺素释放调节中的作用以及α(2)-自动抑制在这些作用中的作用。用[(3)H]-去甲肾上腺素标记雄性Wistar大鼠肠系膜血管环,调节剂对tri溢出的影响由2Hz的100个脉冲(标记为alpha(2)-自抑制)和50Hz或100的20个脉冲引起脉冲以2Hz加上育亨宾(1μM;降低的alpha(2)-自抑制)进行了评估。在两个血管中,血管紧张素II和缓激肽以浓度依赖的方式增强了2Hz处100次脉冲诱发的去甲肾上腺素释放。在减少的alpha(2)-自动抑制的条件下,这些作用减弱。通过激活两个血管中的腺苷A(1)受体和激活静脉中的P2Y受体,部分减弱了衰减。异丙肾上腺素和选择性β(2)-肾上腺素受体激动剂福莫特罗增强tri溢出,独立于静脉中的alpha(2)-自抑制作用。在动脉中,仅在降低的alpha(2)-自动抑制下观察到福莫特罗的增强作用。 β-肾上腺素受体的药理学特征表明,在动脉中,异丙肾上腺素的作用由明显受α(2)-自动抑制作用下的β(1)-亚型和受还原α(2)-作用下的β(2)-亚型介导。自动抑制,而在静脉中的作用与alpha(2)-自动抑制无关。结果表明,α(2)-自抑制作用是血管紧张素II和缓激肽在两种类型的肠系膜血管中引起的促进程度的关键决定因素,并调节由β(1)-和β(2)-肾上腺素受体介导的作用。在动脉中共存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号